Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open exploratory phase 4 study of desloratadine citrate disodium capsules for antihistamine-uncontrolled chronic spontaneous urticaria
ChiCTR2500096851Phase 4Not yet recruiting
- Sponsor
- Bengbu Third People's Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of desloratadine in chronic idiopathic urticaria (CIU) (3 arms), sponsored by Bengbu Third People's Hospital. Primary endpoints: Proportion of patients with completely controlled symptoms during the treatment period and Proportion of recurrent subjects during maintenance treatment. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
desloratadine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on ChiCTR2500096851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096851.